May 9, 2017: Aarkstore announces the publication of its Research Report “Biosimilars: US Payer Perspectives”
Biosimilars continue to be big business in the US, but has progress has been too slow? Not so, argue payers. While the number of biosimilar approvals in the US still lags behind Europe, a solid foundation continues to be laid by multiple key stakeholder groups. Successes have been seen in key areas, including the approval of the first monoclonal ... Read more
The Global Biosimilars Market is rising with a swift phase; mainly owing to enhanced productivity and clinical trial activities for biosimilars and increasing demand for the cheap medical products. There are many recently development due to the expiry of patient of original drugs. In 2015, The U.S. Food and Drug Administration ... Read more
Market Size – USD 5.10 Billion in 2018, Market Growth - CAGR of 30.8%, Market Trends – Product launches and research for advanced Biosimilars
Reports and Data has recently added a comprehensive report titled Global Biosimilars Market which offers complete assessment of current and emerging trends, regional outlook, competitive landscape, and forecast estimation of ... Read more
The global Biosimilars Market is estimated to be valued at US$ 29.4 Bn or in 2023 and is expected to exhibit a CAGR of 17% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Biosimilars are biologic medical products which are highly similar to the reference biologic drugs and provide the same efficacy and safety profile with more affordable costs compared to the ... Read more
